Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers.
暂无分享,去创建一个
[1] A. Basit,et al. Interplay Between Intestinal pH, Transit Time and Feed Status on the In Vivo Performance of pH Responsive Ileo-Colonic Release Systems , 2008, Pharmaceutical Research.
[2] M. Skurnik,et al. Interactions between Yersinia enterocolitica and rabbit ileal mucus: growth, adhesion, penetration, and subsequent changes in surface hydrophobicity and ability to adhere to ileal brush border membrane vesicles , 1991, Infection and immunity.
[3] W. Lehmann,et al. Phosphatidylcholine and lysophosphatidylcholine in intestinal mucus of ulcerative colitis patients. A quantitative approach by nanoelectrospray‐tandem mass spectrometry , 2004, Scandinavian journal of gastroenterology.
[4] Jeffrey R. Wang,et al. Nanoparticulate delivery of novel drug combination regimens for the chemoprevention of colon cancer. , 2010, International journal of oncology.
[5] D. Lewis,et al. The Transfer of Polystyrene Microspheres from the Gastrointestinal Tract to the Circulation after Oral Administration in the Rat , 1995, The Journal of pharmacy and pharmacology.
[6] Soriano,et al. The role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles following oral administration. , 2000, Colloids and surfaces. B, Biointerfaces.
[7] Jung Soo Suk,et al. Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that "slip" through the human mucus barrier. , 2008, Angewandte Chemie.
[8] L. Montagne,et al. Effect of diet on mucin kinetics and composition: nutrition and health implications. , 2004, Nutrition reviews.
[9] P. Artursson,et al. The Influence of Intestinal Mucus Components on the Diffusion of Drugs , 2004, Pharmaceutical Research.
[10] J. Hastewell,et al. Cell biology and active transport processes in the colon , 1991 .
[11] Michael P Boyle,et al. The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles. , 2009, Biomaterials.
[12] R. Juanes,et al. Fluid mixing from viscous fingering. , 2010, Physical review letters.
[13] M. Qiao,et al. Preparation and evaluation of lectin-conjugated PLGA nanoparticles for oral delivery of thymopentin. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[14] Simon C Watkins,et al. Role of intestinal mucus in transepithelial passage of bacteria across the intact ileum in vitro. , 1994, Surgery.
[15] P. Artursson,et al. Diffusion of drugs in native and purified gastrointestinal mucus. , 1997, Journal of pharmaceutical sciences.
[16] J. Kreuter,et al. Quantitative and microautoradiographic study on mouse intestinal distribution of polycyanoacrylate nanoparticles , 1989 .
[17] Frederic Lagarce,et al. Biopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral delivery. , 2010, Nanomedicine.
[18] J. S. Suk,et al. Common Gene Therapy Viral Vectors Do Not Efficiently Penetrate Sputum from Cystic Fibrosis Patients , 2011, PloS one.
[19] T. Kararli. Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals , 1995, Biopharmaceutics & drug disposition.
[20] D. Graham,et al. Helicobacter pylori infection produces reversible glycosylation changes to gastric mucins , 1998, Virchows Archiv.
[21] J. Irache,et al. Preparation and characterization of lectin-latex conjugates for specific bioadhesion. , 1994, Biomaterials.
[22] J. Hanes,et al. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. , 2009, Advanced drug delivery reviews.
[23] G. Russell-Jones,et al. Vitamin B12-mediated transport of nanoparticles across Caco-2 cells. , 1999, International journal of pharmaceutics.
[24] W. Lehmann,et al. Alterations of phospholipid concentration and species composition of the intestinal mucus barrier in ulcerative colitis: A clue to pathogenesis , 2009, Inflammatory bowel diseases.
[25] Omid C Farokhzad,et al. pH-Responsive nanoparticles for drug delivery. , 2010, Molecular pharmaceutics.
[26] W. Stremmel,et al. Lipid Based Therapy for Ulcerative Colitis—Modulation of Intestinal Mucus Membrane Phospholipids as a Tool to Influence Inflammation , 2010, International journal of molecular sciences.
[27] F. Dosio,et al. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential , 2006, International journal of nanomedicine.
[28] R. Poulsom,et al. Alterations in the Composition of the Supramucosal Defense Barrier in Relation to Disease Severity of Ulcerative Colitis , 2006, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[29] F. Autschbach,et al. Delayed Release Phosphatidylcholine in Chronic-active Ulcerative Colitis: A Randomized, Double-blinded, Dose Finding Study , 2009, Journal of clinical gastroenterology.
[30] R. Carrier,et al. Barrier properties of gastrointestinal mucus to nanoparticle transport. , 2010, Macromolecular bioscience.
[31] Alexander T. Florence,et al. Enhanced Oral Uptake of Tomato Lectin-Conjugated Nanoparticles in the Rat , 1997, Pharmaceutical Research.
[32] G. Halbert,et al. The in Vitro Cell Association of Invasin Coated Polylactide-Co-glycolide Nanoparticles , 2000, Pharmaceutical Research.
[33] T. Delair,et al. Traffic of poly(lactic acid) nanoparticulate vaccine vehicle from intestinal mucus to sub-epithelial immune competent cells. , 2010, Biomaterials.
[34] L. Holm,et al. The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo. , 2001, American journal of physiology. Gastrointestinal and liver physiology.
[35] Jianqing Gao,et al. Microemulsions as drug delivery systems to improve the solubility and the bioavailability of poorly water-soluble drugs , 2010, Expert opinion on drug delivery.
[36] Claus-Michael Lehr,et al. Size-Dependent Bioadhesion of Micro- and Nanoparticulate Carriers to the Inflamed Colonic Mucosa , 2001, Pharmaceutical Research.
[37] H. Blom,et al. Gastric mucus gel layer thickness measured by direct light microscopy. An experimental study in the rat. , 1988, Scandinavian journal of gastroenterology.
[38] M. Burger,et al. Wheat germ agglutinin. Molecular characteristics and specificity for sugar binding. , 1974, The Journal of biological chemistry.
[39] A. Macadam. The effect of gastro-intestinal mucus on drug absorption , 1993 .
[40] S. Michalek,et al. Effectiveness of Liposomes Possessing Surface-Linked Recombinant B Subunit of Cholera Toxin as an Oral Antigen Delivery System , 1998, Infection and Immunity.
[41] L. Szentkuti,et al. Light microscopical observations on luminally administered dyes, dextrans, nanospheres and microspheres in the pre-epithelial mucus gel layer of the rat distal colon , 1997 .
[42] Mansoor M Amiji,et al. Gastrointestinal distribution and in vivo gene transfection studies with nanoparticles-in-microsphere oral system (NiMOS). , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[43] J. Hardcastle,et al. Measurement of gastrointestinal pH profiles in normal ambulant human subjects. , 1988, Gut.
[44] A. Slomiany,et al. Lipids associated with rat small-intestinal mucus glycoprotein. , 1983, Carbohydrate research.
[45] M. Burger. Wheat Germ Agglutinin , 2002 .
[46] Alexander T. Florence,et al. Utilizing Bacterial Mechanisms of Epithelial Cell Entry: Invasin-induced Oral Uptake of Latex Nanoparticles , 2004, Pharmaceutical Research.
[47] M. Qiao,et al. Lectin-conjugated PLGA nanoparticles loaded with thymopentin: ex vivo bioadhesion and in vivo biodistribution. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[48] R. Cone,et al. Barrier properties of mucus. , 2009, Advanced drug delivery reviews.
[49] Philip Sutton,et al. Mucin dynamics and enteric pathogens , 2011, Nature Reviews Microbiology.
[50] Clive G. Wilson,et al. Drug delivery to the gastrointestinal tract , 1989 .
[51] G W Halbert,et al. The Uptake and Translocation of Latex Nanospheres and Microspheres after Oral Administration to Rats , 1989, The Journal of pharmacy and pharmacology.
[52] L. Lichtenberger. The hydrophobic barrier properties of gastrointestinal mucus. , 1995, Annual review of physiology.
[53] Yen-Chun Peng,et al. Chemiluminescence assay of mucosal reactive oxygen species in gastric cancer, ulcer and antral mucosa. , 2008, Hepato-gastroenterology.
[54] P Couvreur,et al. Poly(alkyl cyanoacrylate) nanospheres for oral administration of insulin. , 1997, Journal of pharmaceutical sciences.
[55] K. Ribbeck,et al. Characterization of particle translocation through mucin hydrogels. , 2010, Biophysical journal.
[56] R. Newcombe,et al. Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis. , 1994, Gut.
[57] J. Kountouras,et al. Reactive oxygen metabolites and upper gastrointestinal diseases. , 2001, Hepato-gastroenterology.
[58] K. Wan,et al. Glycoprotein mucin molecular brush on cancer cell surface acting as mechanical barrier against drug delivery , 2010 .
[59] Yves-Jacques Schneider,et al. Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[60] V. Préat,et al. Fate of polymeric nanocarriers for oral drug delivery , 2011 .
[61] S. Kerss,et al. A simple method for measuring thickness of the mucus gel layer adherent to rat, frog and human gastric mucosa: influence of feeding, prostaglandin, N-acetylcysteine and other agents. , 1982, Clinical science.
[62] T. Hope,et al. Human Immunodeficiency Virus Type 1 Is Trapped by Acidic but Not by Neutralized Human Cervicovaginal Mucus , 2009, Journal of Virology.
[63] J. Irache,et al. Salmonella-like bioadhesive nanoparticles. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[64] Thomas R. Tice,et al. Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the peyer's patches , 1990 .
[65] Rama Bansil,et al. Mucin structure, aggregation, physiological functions and biomedical applications , 2006 .
[66] M D Donovan,et al. Drug transfer through mucus. , 2001, Advanced drug delivery reviews.
[67] S. Feng. New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers , 2014 .
[68] C. Probert,et al. Mucins and inflammatory bowel disease , 2000, Postgraduate medical journal.
[69] H. Fessi,et al. Polymeric nanoparticles for oral delivery of drugs and vaccines: a critical evaluation of in vivo studies. , 2005, Critical reviews in therapeutic drug carrier systems.
[70] Y. Iiboshi,et al. Role of intestinal mucus on the uptake of latex beads by Peyer's patches and on their transport to mesenteric lymph nodes in rats. , 1999, JPEN. Journal of parenteral and enteral nutrition.
[71] D. Kufe,et al. Mucins in cancer: function, prognosis and therapy , 2009, Nature Reviews Cancer.
[72] Justin Hanes,et al. Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus , 2007, Proceedings of the National Academy of Sciences.
[73] Christopher J H Porter,et al. Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. , 2008, Advanced drug delivery reviews.
[74] T. Desai,et al. Bioadhesive microspheres: III. An in vivo transit and bioavailability study of drug-loaded alginate and poly(fumaric-co-sebacic anhydride) microspheres , 1997 .
[75] P. Sinko,et al. The effect of physical barriers and properties on the oral absorption of particulates. , 1998, Advanced drug delivery reviews.
[76] M. Schenk,et al. The mucosal immune system at the gastrointestinal barrier. , 2008, Best practice & research. Clinical gastroenterology.
[77] Bradley S. Turner,et al. Viscous fingering of HCI through gastric mucin , 1992, Nature.
[78] Michael Wirth,et al. The lectin-cell interaction and its implications to intestinal lectin-mediated drug delivery. , 2004, Advanced drug delivery reviews.
[79] Donald E. Chickering,et al. Biologically erodable microspheres as potential oral drug delivery systems , 1997, Nature.
[80] K. M. Lin,et al. Multi-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[81] J. S. Suk,et al. Rapid transport of muco-inert nanoparticles in cystic fibrosis sputum treated with N-acetyl cysteine. , 2011, Nanomedicine.
[82] Samuel K. Lai,et al. Altering Mucus Rheology to “Solidify” Human Mucus at the Nanoscale , 2009, PloS one.
[83] A. Slomiany,et al. Hydrogen ion diffusion in dog gastric mucus glycoprotein: effect of associated lipids and covalently bound fatty acids. , 1984, Biochemical and biophysical research communications.
[84] A. Basit,et al. An in vivo comparison of intestinal pH and bacteria as physiological trigger mechanisms for colonic targeting in man. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[85] C. Probert,et al. Mucins in the gastrointestinal tract in health and disease. , 2001, Frontiers in bioscience : a journal and virtual library.
[86] M. Amiji,et al. Oral IL-10 gene delivery in a microsphere-based formulation for local transfection and therapeutic efficacy in inflammatory bowel disease , 2008, Gene Therapy.
[87] N Hussain,et al. Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics. , 2001, Advanced drug delivery reviews.
[88] Sanjay K. Jain,et al. In vitro and cell uptake studies for targeting of ligand anchored nanoparticles for colon tumors. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[89] J. Robinson,et al. Some biological issues in oral, controlled drug delivery , 1987 .
[90] Giovanni Filippo Palmieri,et al. Mucoadhesion mechanism of chitosan and thiolated chitosan-poly(isobutyl cyanoacrylate) core-shell nanoparticles. , 2007, Biomaterials.
[91] P. Lowe,et al. Calcitonin and Insulin in Isobutylcyanoacrylate Nanocapsules: Protection Against Proteases and Effect on Intestinal Absorption in Rats , 1994, The Journal of pharmacy and pharmacology.
[92] Maria José Alonso,et al. Comparative Uptake Studies of Bioadhesive and Non-Bioadhesive Nanoparticles in Human Intestinal Cell Lines and Rats: The Effect of Mucus on Particle Adsorption and Transport , 2002, Pharmaceutical Research.
[93] K. Okazaki,et al. Gastric mucin hydrophobicity: effects of associated and covalently bound lipids, proteolysis, and reduction. , 1988, Biochemistry international.
[94] A. I. Yudin,et al. Diffusion of macromolecules and virus-like particles in human cervical mucus. , 2001, Biophysical journal.
[95] J. Pearson,et al. The gastroduodenal mucus barrier and its role in protection against luminal pepsins: The effect of 16,16 dimethyl prostaglandin E2, carbopol‐polyacrylate, sucralfate and bismuth subsalicylate , 1994, Journal of gastroenterology and hepatology.
[96] Mansoor M Amiji,et al. Polymeric nano- and microparticle technologies for oral gene delivery , 2007, Expert opinion on drug delivery.
[97] C. Fiocchi. Handbook of mucosal immunology , 1994 .
[98] Michael A. Hollingsworth,et al. Mucins in cancer: protection and control of the cell surface , 2004, Nature Reviews Cancer.
[99] D. Owen,et al. Histochemical alterations of mucin in normal colon, inflammatory bowel disease and colonic adenocarcinoma , 2004, The Histochemical Journal.
[100] A. Slomiany,et al. Effect of lipids and proteins on the viscosity of gastric mucus glycoprotein. , 1984, Biochemical and biophysical research communications.
[101] H Lennernäs,et al. Chitosans as absorption enhancers of poorly absorbable drugs. 3: Influence of mucus on absorption enhancement. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[102] C. Lehr,et al. Lectin-mediated drug targeting: history and applications. , 2004, Advanced drug delivery reviews.
[103] A. Vila,et al. Design of biodegradable particles for protein delivery. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[104] Claus-Michael Lehr,et al. Bioadhesion by Means of Specific Binding of Tomato Lectin , 1992, Pharmaceutical Research.
[105] D. Bhalla,et al. Cytochemical analysis of alkaline phosphatase and esterase activities and of lectin-binding and anionic sites in rat and mouse Peyer's patch M cells. , 1983, The American journal of anatomy.
[106] B. Hirst,et al. Lectin-mediated mucosal delivery of drugs and microparticles. , 2000, Advanced drug delivery reviews.
[107] Justin Hanes,et al. Biodegradable nanoparticles composed entirely of safe materials that rapidly penetrate human mucus. , 2011, Angewandte Chemie.
[108] S. Ganta,et al. A review of stimuli-responsive nanocarriers for drug and gene delivery. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[109] Y. Kawashima,et al. Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease. , 2001, The Journal of pharmacology and experimental therapeutics.
[110] P. Artursson,et al. Transport of nanoparticles across an in vitro model of the human intestinal follicle associated epithelium. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[111] J. Sheehan,et al. Structure and macromolecular properties of mucus glycoproteins. , 1988, Monographs in allergy.
[112] J Woodley,et al. Bioadhesion: new possibilities for drug administration? , 2001, Clinical pharmacokinetics.
[113] Hirofumi Takeuchi,et al. Novel mucoadhesion tests for polymers and polymer-coated particles to design optimal mucoadhesive drug delivery systems. , 2005, Advanced drug delivery reviews.
[114] H. Florey. The secretion and function of intestinal mucus. , 1962, Gastroenterology.
[115] Samuel K. Lai,et al. Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses , 2009, Proceedings of the National Academy of Sciences.
[116] R Weltzin,et al. Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting , 1996, The Journal of experimental medicine.
[117] T. Yen,et al. Biodistribution, pharmacodynamics and pharmacokinetics of insulin analogues in a rat model: Oral delivery using pH-responsive nanoparticles vs. subcutaneous injection. , 2010, Biomaterials.
[118] D. A. McCormick,et al. Mucin depletion in inflammatory bowel disease. , 1990, Journal of clinical pathology.
[119] Benjamin C. Tang,et al. Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier , 2009, Proceedings of the National Academy of Sciences.
[120] Hirofumi Takeuchi,et al. Mucoadhesive DL-Lactide/Glycolide Copolymer Nanospheres Coated with Chitosan to Improve Oral Delivery of Elcatonin , 2000, Pharmaceutical development and technology.
[121] Ick Chan Kwon,et al. Targeted delivery of low molecular drugs using chitosan and its derivatives. , 2010, Advanced drug delivery reviews.
[122] Anil Kumar Bajpai,et al. Responsive polymers in controlled drug delivery , 2008 .
[123] Denis Wirtz,et al. Micro- and macrorheology of mucus. , 2009, Advanced drug delivery reviews.
[124] G. Mullin,et al. Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease , 1996, Digestive Diseases and Sciences.
[125] S. Melgar,et al. Intestinal delivery of non-viral gene therapeutics: physiological barriers and preclinical models. , 2011, Drug discovery today.
[126] B. Tirosh,et al. Migration of adhesive and nonadhesive particles in the rat intestine under altered mucus secretion conditions. , 1998, Journal of pharmaceutical sciences.
[127] S. Dai,et al. Aggregation behavior of methacrylic acid/ethyl acrylate copolymer in dilute solutions , 2000 .
[128] F. Martin,et al. Phospholipids and Lipid-Based Formulations in Oral Drug Delivery , 2010, Pharmaceutical Research.
[129] Didier Merlin,et al. Orally delivered thioketal nanoparticles loaded with TNF-α-siRNA target inflammation and inhibit gene expression in the intestines. , 2010, Nature materials.
[130] Krishnendu Roy,et al. Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy , 1999, Nature Medicine.